Clinical Trial Update: An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache [Phase 4]

View source ↗

Summary

This is a Phase 4 open-label trial evaluating duloxetine for comorbid major depressive disorder and chronic primary headache. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Kraepelin Psiquiatria Clinica | Conditions: Major Depression, Chronic Primary Headache | Phase 4 | Status: COMPLETED